United States newsroom

SAN FRANCISCO, CA and NORTHBROOK, IL – October 30, 2014 – Medivation Inc. (NASDAQ: MDVN) and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate the...

Company is Exclusive Healthcare Sponsor of USA Eagles vs. New Zealand All Blacks Rugby Match at Soldier Field on Nov. 1 NORTHBROOK, Ill., Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., in...

NORTHBROOK, Ill., Oct. 8, 2014 /PRNewswire/ -- Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3...

NORTHBROOK, Ill., Oct. 2, 2014 /PRNewswire/ -- Astellas, a pharmaceutical company based in Northbrook, Ill., launched a new benefits program today to provide support for its almost 3,000 US-based...

NORTHBROOK, Ill., Oct. 1, 2014 /PRNewswire/ -- Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. In this role, Brian will be...

NORTHBROOK, Ill., Sept. 16, 2014 /PRNewswire/ -- Astellas announced today it has appointed Christy Noland as a new director of Business Communications & Advocacy, Urology in the Americas. Noland...

WHAT: More than 400 Astellas employees will descend on Dunning Read Conservation Area in Chicago in celebration of Astellas 5th annual Changing Tomorrow Day. The volunteers will build a...

NORTHBROOK, Ill., Sept. 6, 2014 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for isavuconazole...

NORTHBROOK, Ill., Sept. 5, 2014 /PRNewswire/ -- Astellas today announces the appointment of Andrew Lewis as head of communications for the company's Global Medical & Development (GMD)...

NORTHBROOK, Ill., Sept. 5, 2014 /PRNewswire/ -- Astellas announces today the data that will be presented on the anti-fungal isavuconazole at the 4th Interscience Conference on Antimicrobial Agents...